Basic information
- CAS
89667-40-3- Standard SMILES
O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1- InChIKey
UWPBQLKEHGGKKD-GZTJUZNOSA-N- Molecular formula
- C18H19NO2
- Average molar mass
- 281.3 g/mol
- Monoisotopic mass
- 281.14157885
Overview
Isbogrel is a small molecule drug. Isbogrel has a monoisotopic molecular weight of 281.14 Da.
Names & identifiers
- Preferred name
- Isbogrel
- IUPAC
- (E)-7-phenyl-7-pyridin-3-ylhept-6-enoic acid
- English name
- ISBOGREL
- Molecular formula
- C18H19NO2
- Molecular weight
- 281.35
Names & synonyms
Show more names
Database identifiers
- CAS
89667-40-3- PubChem CID
- 5284442
- DTXSID
DTXSID4021133- ChEMBL
CHEMBL26820、CHEMBL28196- UNII
- HGB7P08R36
- EC Number
- 887-203-5
- Nikkaji
- J22.155D
Properties
Computed structural properties
- XLogP
- 4
- Topological polar surface area
- 50.2 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 3
- Rotatable bonds
- 7
- Heavy atoms
- 21
- Formal charge
- 0
- Complexity
- 345
Physicochemical properties
- Melting point
- 114 · 114-115°
- storage temp.
- 2 · 2-8°C
- FDA UNII
- 7 P08R36 · HGB7P08R36
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 315 · H315-H319
- Precautionary statements
- 264 · P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
Safety & regulation
GHS classification
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Hazard information
Safety data
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Hazard statements
- H315-H319
- Precautionary statements
- P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
Applications
UsesIsbogrel is used as Thromboxane A2 inhibitor and for the treatment of short-term myocardial ischemia.
Upstream & downstream products
Upstream raw materials
Suppliers8 total
Related reactions
Compound notes
Loading…